Researchers have begun clinical testing on prototype vaccinations for COVID-19. For these vaccinations to be released to the public they must be FDA approved (Food and Drug Administration).

In order for the FDA to approve the vaccine, it must prevent an infection or decrease the possibility of an individual becoming ill. As a precaution, researchers test approximately 50 people regulating the dosage and monitoring the efficacy (meaning the ability to produce a desired or intended result). They start off with a small population, so that if the vaccine is ineffective, the researchers can identify a solution.

The National Institute of Health states, “The ongoing phase one trial is supported by the National Institutes of Allergy and Infectious Diseases, part of the National institute of health.” Their clinic is working with the company Johnson & Johnson to come out with a vaccination.

Phase two helps the vaccination expand. First, vaccine manufactures must show to the government that the vaccine they’re working on is safe to use on people to move on. After, the researchers start to expand the safety trials to hundreds of people. The study start date was April 12, 2020, the estimated primary competition date is January 31, 2021 — as well as, the estimated study completion date (finished product) is also, January 31, 2021.

“Doctors say CDC should warn people the side effects from COVID vaccine shots won’t be a walk in the park. The CDC must be transparent about the side effects people may experience after getting their first shot of coronavirus vaccine, doctors urged during a meeting Monday with CDC advisors.” The site CNBC states.

The last phase becomes worldwide so many people can volunteer for the vaccination. This is the largest trials scale according to CNN. The tests will be expanded to thousands of people with some receiving a placebo. The researchers can find the side effects in a larger population. The dosage and efficacy are one of the most important parts of this trial because if the government allows the vaccine to be released and it is not ready something could go terribly wrong.

“The trial is designed to evaluate if the investigational Janssen COVID-19 vaccine can prevent symptomatic COVID-19 after a single dose regimen”, the National Institute of Health stated.

Suffolk University put out a poll for “When a federally-approved vaccine is available, will you…” The options included: not take it, undecided, wait until others have taken it and take it immediately. For not taking it the percentage was 23%, wait until others have taken it was 44%, take it immediately was 27% and undecided was 6%. The website U.S news states that as of November 18, 2020, “PFIZER’S CORONAVIRUS vaccine is 95% effective in preventing the coronavirus and has no serious side effects, a final analysis of the company’s phase three trial shows.”

There have been plenty of volunteers to try for the vaccination. The CDC recommends that children (ages three to twelve) or pregnant adults not to take the vaccine. The researchers feel as if kids and pregnant adults, something could go wrong easily with the side effects they haven’t worked out yet. Pharmacy’s like Walgreens and CVS already have people in line waiting for the COVID-19 vaccine. They’re like preorders but for vaccine.

The CDC says “Children, who rarely have severe COVID-19 symptoms, have not yet been tested for any experimental coronavirus vaccine.”